Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 21, 2021 - Issue 2
Submit an article Journal homepage
1,075
Views
45
CrossRef citations to date
0
Altmetric
Review

Recent developments of RNA-based vaccines in cancer immunotherapy

Elnaz Faghfuria Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, IranCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2002-2525
ORCID Icon,
Farhad Pourfarzia Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, IranORCID Iconhttps://orcid.org/0000-0001-6442-6340
ORCID Icon,
Amir Hossein Faghfourib Student’s Research Committee, Department of Nutrition, Tabriz University of Medical Science, Tabriz, IranORCID Iconhttps://orcid.org/0000-0003-0356-7267
ORCID Icon,
Mahdi Abdoli Shadbadc Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
,
Khalil Hajiasgharzadehc Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, IranORCID Iconhttps://orcid.org/0000-0003-4593-4803
ORCID Icon &
Behzad Baradaranc Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, IranCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8642-6795
ORCID Icon
Pages 201-218 | Received 03 May 2020, Accepted 24 Aug 2020, Published online: 03 Sep 2020

Citations (45)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yingying Xu, Yijing Zheng, Xuqiu Ding, Chengyan Wang, Bin Hua, Shilian Hong, Xiaoman Huang, Jiali Lin, Peng Zhang & Wei Chen. (2023) PEGylated pH-responsive peptide-mRNA nano self-assemblies enhance the pulmonary delivery efficiency and safety of aerosolized mRNA. Drug Delivery 30:1.
Read now
Sophia Konig, Hannah Strobel, Michael Grunert, Marcin Lyszkiewicz, Oliver Brühl, Georg Karpel-Massler, Natalia Ziętara, Katia La Ferla-Brühl, Markus D. Siegelin, Klaus-Michael Debatin & Mike-Andrew Westhoff. (2022) Unblinding the watchmaker: cancer treatment and drug design in the face of evolutionary pressure. Expert Opinion on Drug Discovery 17:10, pages 1081-1094.
Read now

Articles from other publishers (43)

Zhihui Duan, Dandan Yang, Ping Yuan, Xiaoming Dai, Guodong Chen & Daichao Wu. (2024) Advances, opportunities and challenges in developing therapeutic cancer vaccines. Critical Reviews in Oncology/Hematology 193, pages 104198.
Crossref
Garima Sahu, Priyanka Kumari & Amit K. Goyal. 2024. Molecular Pharmaceutics and Nano Drug Delivery. Molecular Pharmaceutics and Nano Drug Delivery 15 62 .
José Dario Portillo-Miño, David Bettin-Gonzalez & Franco Andrés Montenegro Coral. (2023) mRNA vaccines in gastric cancer: How close are we?. Vacunas.
Crossref
Lang Li, Lvyuan He & Ying Zhu. (2023) Dissecting tumor antigens and immune subtypes for mRNA vaccine development in breast cancer. Journal of Big Data 10:1.
Crossref
Alexandro Guterres, Mayla Abrahim & Patrícia Cristina da Costa Neves. (2023) The role of immune subtyping in glioma mRNA vaccine development. Immunotherapy 15:13, pages 1057-1072.
Crossref
Londiwe Simphiwe Mbatha, Jude Akinyelu, Fiona Maiyo & Tukayi Kudanga. (2023) Future prospects in mRNA vaccine development. Biomedical Materials 18:5, pages 052006.
Crossref
Zhe Wang, Wanting Ma, Xingxing Fu, Yanfei Qi, Yinan Zhao & Shubiao Zhang. (2023) Development and applications of mRNA treatment based on lipid nanoparticles. Biotechnology Advances 65, pages 108130.
Crossref
Prithwish Kola, Prasanth Kumar Bhusetty Nagesh, Pritam Kumar Roy, K. Deepak, Rui Luis Reis, Subhas C. Kundu & Mahitosh Mandal. (2023) Innovative nanotheranostics: Smart nanoparticles based approach to overcome breast cancer stem cells mediated chemo‐ and radioresistances. WIREs Nanomedicine and Nanobiotechnology 15:4.
Crossref
Samvedna Saini, Pranjal Dagar, Sakshi Gupta & Yatender Kumar. (2023) A nanotherapeutic approach for fighting the odds against the malignant disorders. Journal of Nanoparticle Research 25:6.
Crossref
Shi Yang, Han Yu, Xiuli Xu, Ting Yang, Yue Wei, Rui Zan, Xiaonong Zhang, Qingming Ma, Ho Cheung Shum & Yang Song. (2023) AIEgen-Conjugated Phase-Separating Peptides Illuminate Intracellular RNA through Coacervation-Induced Emission. ACS Nano 17:9, pages 8195-8203.
Crossref
Nasser Hashemi Goradel, Mahnaz Nemati, Azam Bakhshandeh, Arash Arashkia & Babak Negahdari. (2023) Nanovaccines for cancer immunotherapy: Focusing on complex formation between adjuvant and antigen. International Immunopharmacology 117, pages 109887.
Crossref
Han Sun, Yu Zhang, Ge Wang, Wen Yang & Yingjie Xu. (2023) mRNA-Based Therapeutics in Cancer Treatment. Pharmaceutics 15:2, pages 622.
Crossref
Matteo Puccetti, Aurelie Schoubben, Stefano Giovagnoli & Maurizio Ricci. (2023) Biodrug Delivery Systems: Do mRNA Lipid Nanoparticles Come of Age?. International Journal of Molecular Sciences 24:3, pages 2218.
Crossref
Brayden K. Leyva & Benjamin Bonavida. 2023. Nitric Oxide in Health and Disease. Nitric Oxide in Health and Disease 151 172 .
M. Vindhya, M. N. Ramesh Bharadwaj, Kanthesh M. Basalingappa, T. S. Gopenath & Ashok Gnanasekaran. 2023. Targeted Cancer Therapy in Biomedical Engineering. Targeted Cancer Therapy in Biomedical Engineering 179 217 .
Xin Xin & Wei Huang. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 17 .
Changwu Wu, Chaoying Qin, Wenyong Long, Xiangyu Wang, Kai Xiao & Qing Liu. (2022) Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy development. Journal of Big Data 9:1.
Crossref
Yan Chen, Ning Jiang, Meihua Chen, Baiyan Sui & Xin Liu. (2022) Identification of tumor antigens and immune subtypes in head and neck squamous cell carcinoma for mRNA vaccine development. Frontiers in Cell and Developmental Biology 10.
Crossref
Chang Liu, Min Wang, Haiyang Zhang, Chunyan Li, Tianshou Zhang, Hong Liu, Song Zhu & Jie Chen. (2022) Tumor microenvironment and immunotherapy of oral cancer. European Journal of Medical Research 27:1.
Crossref
Cathrine Lund Lorentzen, John B Haanen, Özcan Met & Inge Marie Svane. (2022) Clinical advances and ongoing trials on mRNA vaccines for cancer treatment. The Lancet Oncology 23:10, pages e450-e458.
Crossref
Ting Huang, Li Liu, Zheng Lv, Kelei Zhao, Qiong Yi & Jing Zhang. (2022) Recent Advances in DNA Vaccines against Lung Cancer: A Mini Review. Vaccines 10:10, pages 1586.
Crossref
Wout De Mey, Arthur Esprit, Kris Thielemans, Karine Breckpot & Lorenzo Franceschini. (2022) RNA in Cancer Immunotherapy: Unlocking the Potential of the Immune System. Clinical Cancer Research 28:18, pages 3929-3939.
Crossref
Weiran Liao, Zhitian Shi, Haoren Tang, Tiangen Wu, Cheng Zhang, Yutao He, Renchao Zou & Lin Wang. (2022) Identifying Potential Tumor Antigens and Antigens-Related Subtypes in Hepatocellular Carcinoma for mRNA Vaccine Development. Journal of Oncology 2022, pages 1-12.
Crossref
Tao Huang, Lushan Peng, Yingying Han, Dan Wang, Xiaoyun He, Junpu Wang & Chunlin Ou. (2022) Lipid nanoparticle-based mRNA vaccines in cancers: Current advances and future prospects. Frontiers in Immunology 13.
Crossref
Weiqiang You, Jian Ouyang, Zerong Cai, Yufeng Chen & Xiaojian Wu. (2022) Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination. Frontiers in Immunology 13.
Crossref
Qing He, Hua Gao, Dejiang Tan, Heng Zhang & Jun-zhi Wang. (2022) mRNA cancer vaccines: Advances, trends and challenges. Acta Pharmaceutica Sinica B 12:7, pages 2969-2989.
Crossref
Zhuoya Deng, Yuying Tian, Jianxun Song, Guangwen An & Penghui Yang. (2022) mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy. Frontiers in Immunology 13.
Crossref
Bita Amir Taghavi, Nazila Alizadeh, Hossein Saeedi, Noora Karim Ahangar, Afshin Derakhshani, Khalil Hajiasgharzadeh, Nicola Silvestris, Behzad Baradaran & Oronzo Brunetti. (2022) Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy. Molecules 27:11, pages 3545.
Crossref
Li-Juan Duan, Qian Wang, Cuilian Zhang, Dong-Xiao Yang & Xu-Yao Zhang. (2022) Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy. Frontiers in Immunology 13.
Crossref
Thien Nguyen, Sabine Mueller & Fatema Malbari. (2022) Review: Neurological Complications From Therapies for Pediatric Brain Tumors. Frontiers in Oncology 12.
Crossref
Elnaz Faghfuri, Mahdi Abdoli Shadbad, Amir Hossein Faghfouri & Narges Soozangar. (2022) Cellular immunotherapy in gastric cancer: adoptive cell therapy and dendritic cell-based vaccination. Immunotherapy 14:6, pages 475-488.
Crossref
Jian Liu, Minyang Fu, Manni Wang, Dandan Wan, Yuquan Wei & Xiawei Wei. (2022) Cancer vaccines as promising immuno-therapeutics: platforms and current progress. Journal of Hematology & Oncology 15:1.
Crossref
Rui Cheng, Zhaochun Xu, Meng Luo, Pingping Wang, Huimin Cao, Xiyun Jin, Wenyang Zhou, Lixing Xiao & Qinghua Jiang. (2022) Identification of alternative splicing-derived cancer neoantigens for mRNA vaccine development. Briefings in Bioinformatics 23:2.
Crossref
Qiankun Ni, Fengfei Xu, Yufei Wang, Yujie Li, Guangchao Qing, Yuxuan Zhang, Jie Zhong, Jinghong Li & Xing-Jie Liang. (2022) Nanomaterials with changeable physicochemical property for boosting cancer immunotherapy. Journal of Controlled Release 342, pages 210-227.
Crossref
Changwu Wu, Yingjuan Duan, Siming Gong, Georg Osterhoff, Sonja Kallendrusch & Nikolas Schopow. (2022) Identification of Tumor Antigens and Immune Subtypes for the Development of mRNA Vaccines and Individualized Immunotherapy in Soft Tissue Sarcoma. Cancers 14:2, pages 448.
Crossref
Akihiro Watanabe, Kimihiro Yamashita, Mitsugu Fujita, Akira Arimoto, Masayasu Nishi, Shiki Takamura, Masafumi Saito, Kota Yamada, Kyosuke Agawa, Tomosuke Mukoyama, Masayuki Ando, Shingo Kanaji, Takeru Matsuda, Taro Oshikiri & Yoshihiro Kakeji. (2021) Vaccine Based on Dendritic Cells Electroporated with an Exogenous Ovalbumin Protein and Pulsed with Invariant Natural Killer T Cell Ligands Effectively Induces Antigen-Specific Antitumor Immunity. Cancers 14:1, pages 171.
Crossref
Lei Miao, Yu Zhang & Leaf Huang. (2021) mRNA vaccine for cancer immunotherapy. Molecular Cancer 20:1.
Crossref
Mahdi Abdoli Shadbad, Zahra Asadzadeh, Afshin Derakhshani, Negar Hosseinkhani, Ahad Mokhtarzadeh, Amir Baghbanzadeh, Khalil Hajiasgharzadeh, Oronzo Brunetti, Antonella Argentiero, Vito Racanelli, Nicola Silvestris & Behzad Baradaran. (2021) A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery. Biomedicine & Pharmacotherapy 143, pages 112213.
Crossref
Maria L. Ibba, Giuseppe Ciccone, Carla L. Esposito, Silvia Catuogno & Paloma H. Giangrande. (2021) Advances in mRNA non-viral delivery approaches. Advanced Drug Delivery Reviews 177, pages 113930.
Crossref
Minsong Gao, Qingyi Zhang, Xin-Hua Feng & Jianzhao Liu. (2021) Synthetic modified messenger RNA for therapeutic applications. Acta Biomaterialia 131, pages 1-15.
Crossref
Chiara Rinoldi, Seyed Shahrooz Zargarian, Pawel Nakielski, Xiaoran Li, Anna Liguori, Francesca Petronella, Dario Presutti, Qiusheng Wang, Marco Costantini, Luciano De Sio, Chiara Gualandi, Bin Ding & Filippo Pierini. (2021) Nanotechnology‐Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID‐19 Vaccines. Small Methods 5:9.
Crossref
Youri Hoogstrate & Pim J French. (2021) You spin me right ‘round. Neuro-Oncology 23:5, pages 707-708.
Crossref
Yue Yin, Xiaoyang Li, Haixia Ma, Jie Zhang, Di Yu, Ruifang Zhao, Shengji Yu, Guangjun Nie & Hai Wang. (2021) In Situ Transforming RNA Nanovaccines from Polyethylenimine Functionalized Graphene Oxide Hydrogel for Durable Cancer Immunotherapy . Nano Letters 21:5, pages 2224-2231.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.